Big reveal is going to happen at KIMES fairs in Seoul. SMARTTECH together with its Korean Distributor, the KAIS Company, will present the 3D scanning technologies dedicated to medicine. KIMES provides attendants with the opportunity to identify and confirm the great potential and prospect of the future medical industry as well as the latest medical industry trend as a venue where 1,200 domestic…
Employing new photonics technology, European scientists are developing a new Augmented Reality surgical visor in a bid to improve accuracy of interventions, showing anaesthetic and medical data while superimposing a patient’s x-ray in perfect unison with their body, meaning surgeons never having to look away during an operation and surgery times reduced by over 20 minutes for every 3 hours.
Structured reporting in radiology is easier to say than do. Initially radiologists must agree on the structure of the report itself. Then they need to agree on what to report. Those two very different challenges help to explain why migration into the Digital Age of radiology reports is moving at Ice Age speed.
New 3-D simulation models that include haemodynamics enable better treatment of hepatic tumours via radio-embolisation, according to eminent Spanish radiologist José Ignacio Bilbao Jaureguizar.
Focused ultrasound can effectively destroy tumor cells. Until now, this method has only been used for organs such as the prostate and uterus. At the European Congress of Radiology, Fraunhofer researchers will present a method, developed as part of the TRANS-FUSIMO EU project, that enables focused ultrasound treatment of the liver, an organ that moves while breathing. In the future, this could…
The job title radiographer has a firm place in many European and non-European countries. The academic training reflects the complex range of responsibilities the role entails.
In an exclusive interview, Mauricio Castillo, president of the American Roentgen Ray Society (ARRS), spoke about the impact of dissatisfaction and gender discrimination in radiology, the focus of his Wilhelm Conrad Roentgen Honorary Lecture at ECR 2017.
BMJ Journal will continue to campaign for a healthier world guided by evidence.
New state-of-the-art technology helps clinicians provide personalised pain relief
RDT, a leading provider of pre-hospital care solutions, will be previewing its Tempus ALS™ monitor defibrillator at Arab Health 2017. Visitors to Stand Z1A59 will be able to see this innovative solution – which offers the benefits of a fully ERC-compliant defibrillator and an advanced monitor in a small and lightweight package – ahead of its official launch later in the year.
Biosimilars create opportunities for sustainable cancer care, says the European Society for Medical Oncology (ESMO) in a position paper published in ESMO Open.1 The document outlines approval standards for biosimilars, how to safely introduce them into the clinic, and the potential benefits for patients and healthcare systems.
InterMed exhibition is a professional platform for the leading foreign clinics, medical and health centres working or planning to work with Russian patients, as well as an effective tool for expanding the agent network in Russia.
First thing on a recent Monday morning, Professor Tomasz Grodzki could be found performing a lung resection in an operating theatre at the Regional Hospital for Lung Diseases in Szczecin-Zdunowo. Just two days earlier he was in a meeting with Senator John McCain, in Washington D.C.
A combination of a diabetes medication and an antihypertensive drug can effectively combat cancer cells. The team of researchers led by Prof. Michael Hall at the Biozentrum of the University of Basel has also reported that specific cancer cells respond to this combination of drugs.
Columbia University Medical Center (CUMC) researchers have created a computational tool that can rapidly predict which genes are implicated in an individual’s cancer and recommend treatments. It is among the most comprehensive tools of its kind, and the first that incorporates a user-friendly web interface that requires little knowledge of bioinformatics.
Cedars-Sinai neurosurgeons have begun using a high-definition imaging device to see inside the brain during surgery, allowing them to map safer pathways to reach and remove tumors.
Before an operation, surgeons have to obtain the most precise image possible of the anatomical structures of the part of the body undergoing surgery. University of Basel researchers have now developed a technology that uses computed tomography data to generate a three-dimensional image in real time for use in a virtual environment.
Faster and better recovery after stroke may be the result of a newly discovered treatment strategy that created new nerve synapses in the brain—a key factor for learning. A study at Sahlgrenska Academy showed improved ability to use the affected paw in mice that received the treatment.
A team of UCLA bioengineers has demonstrated that its technology may go a long way toward overcoming the challenges of treatment for acute lymphoblastic leukemia, among the most common types of cancer in children, and has the potential to help doctors personalize drug doses.
ETH Researchers have used the simplest approach yet to produce artificial beta cells from human kidney cells. Like their natural model, the artificial cells act as both sugar sensors and insulin producers.
Angelina Jolie received widespread media attention in 2013 when she told the public that she'd tested positive for BRCA1, a gene associated with an increased risk of breast and ovarian cancers, and subsequently had a double mastectomy. Now research shows a spike in genetic tests for breast cancer after actress’ public disclosure, but no corresponding increase in mastectomies.
The implantation of knee and hip joints is considered one of the success stories of recent years. But periprosthetic joints infections (PJI) are one of the severe complications, with an infection rate of 2%. The probability of revision surgery increases with concomitant diseases such as rheumatoid arthritis, with fracture prosthesis or after previous surgery.
Remote Diagnostic Technologies Ltd (RDT) previewed its Tempus ALS™ monitor defibrillator at MEDICA 2016, ahead of its official launch in early 2017. Tempus ALS offers the benefits of a fully ERC-compliant defibrillator and an advanced monitor in a small and lightweight package.
University of Adelaide researchers have developed an optical fiber probe that distinguishes breast cancer tissue from normal tissue – potentially allowing surgeons to be much more precise when removing breast cancer.
When Kerstin Stenson, MD, describes the innovative technique she is helping develop to fight cancer, it seems like she’s describing a Tom Clancy military espionage novel.